Mesa Laboratories (MLAB) Cash Flow Statement

Click line-items for a historical chart and %

Cash Flows From Operating Activities:
Net Income
Depreciation and Amortization	4.41M
Stock Based Compensation	841K
Gain on Loan Settlement
Change in Assets and Liabilities-
(Increase) Decrease in Accounts Receivable, net	1.9M
(Increase) Decrease in Inventories	-348K
(Increase) Decrease in Prepaid Expenses	-509K
Increase (Decrease) in Accounts Payable	661K
Increase (Decrease) in Accrued Liabilities	-5.39M
Net Cash and Cash Equivalents Provided by Operating Activities
Cash Flows From Investing Activities:
Acquisition of Product Lines and Company
Deposits
Capital Expenditures, Building
Capital Expenditures, Net of Retirements	-6.67M
Net Cash and Cash Equivalents (Used) in Investing Activities
Cash Flows From Financing Activities:
Bank Borrowing, Net of Debt Payments
Dividends Paid
Treasury Stock Purchases
Proceeds From Stock Options Exercised	1.77M
Net Cash and Cash Equivalents (Used) Provided by Financing Activities
Net Increase (Decrease) In Cash and Cash Equivalents	-625K
Cash and Cash Equivalents at Beginning of Period	5.7M
Cash and Cash Equivalents at End of Period	5.07M
Cash paid for Interest	588K
Supplemental disclosure of non-cash activity:
The Company issued employee loans for the purchase of common stock during the three month period ended June 30, 2011 and 2010, respectively
Loans outstanding retired

Entities mentioned with MLAB